Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01687673
Title Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Francisco San Francisco California 94143 United States Details
Robert H Lurie Comprehensive Cancer Center Chicago Illinois 60611 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field